The Drug Enforcement Administration should not be part of the cannabis research application process. That is the main recommendation the National Cannabis Industry Association (NCIA) to the federal agency currently overseeing the federal medical cannabis research program.
The recommendation, sent on May 11, comes in response to the DEA’s request for information on controls to enhance the cultivation of marijuana for research in the United States. On March 23, the DEA announced it was seeking public comment on its proposal to “amend its regulations to comply with the requirements of the Controlled Substances Act, including consistency with treaty obligations, in order to facilitate the cultivation of cannabis for research purposes and other licit purposes.”
Among other reasons, the NCIA highlights the DEA’s sluggish processing of current applications to explain why the law enforcement agency is not the right fit to lead cannabis research initiatives.
Read full article here: https://www.cannabisbusinesstimes.com/article/ncia-calls-dea-cannabis-oversight-change/